easy to swallow, hard to absorb
Breakthroughs in Oral Delivery of Peptides, Nucleic Acids, and Biologics
A science-first, problem-solving session focused on one of drug development’s most persistent challenges: turning complex macromolecules into practical oral medicines. The Live Lab will examine the formulation, biopharmaceutic, delivery, translational, and manufacturing hurdles that stand between promising peptides, nucleic acids, and biologics—and meaningful oral exposure.
As a sponsor, you’ll be embedded in these sessions—sharing your solutions directly with formulation scientists, biotech innovators, CMC leads, and CDMO partners.
who you'll meet
✓ Formulation Scientists, CMC Leads, Regulatory Strategists
✓ Drug Delivery Experts, PK/PD Scientists, Medicinal Chemists
✓ Biotech Executives, CDMOs, and Strategic Development Leaders
✓ Approximately 150 senior attendees
opening
10-minute scene-setting introduction led by Manuel Sanchez-Felix, framing the scientific landscape, current barriers, and where oral delivery is advancing.
3–4 SCIENTIFIC CASE STUDIES
CDMOs and sponsors present real-world problem solving: the hurdle, the
scientific or manufacturing approach, what was learned, and the practical capability that enabled progress. Presentations are capabilities-focused—not sales pitches.
LIVE LAB DISCUSSION
Interactive discussion connects the case studies across permeability, stability, GI biology, formulation, device/technology choices, scale-up, manufacturability, and clinical translation.
TAKE-HOME ROADMAP
Close with shared lessons, remaining technical gaps, and the capabilities
needed to move oral peptides, nucleic acids, and biologics from concept
toward scalable patient-centric products.
Learn more about the AI Live Lab happening on Thursday, December 10th, 2026.
